Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications.

Bover J, Ureña-Torres P, Laiz Alonso AM, Torregrosa JV, Rodríguez-García M, Castro-Alonso C, Górriz JL, Benito S, López-Báez V, Lloret Cora MJ, Cigarrán S, DaSilva I, Sánchez-Bayá M, Mateu Escudero S, Guirado L, Cannata-Andía J.

Nefrologia. 2019 Feb 20. pii: S0211-6995(19)30012-8. doi: 10.1016/j.nefro.2018.10.009. [Epub ahead of print] Review. English, Spanish.

2.

Bone management in hematologic stem cell transplant recipients.

Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, El Maghraoui A, Guglielmi G, Hadji P, Pierroz DD, de Villiers TJ, Rizzoli R, Ebeling PR; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease.

Osteoporos Int. 2018 Dec;29(12):2597-2610. doi: 10.1007/s00198-018-4669-4. Epub 2018 Sep 3. Review.

PMID:
30178158
3.

Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.

Bover J, Ureña-Torres P, Torregrosa JV, Rodríguez-García M, Castro-Alonso C, Górriz JL, Laiz Alonso AM, Cigarrán S, Benito S, López-Báez V, Lloret Cora MJ, daSilva I, Cannata-Andía J.

Nefrologia. 2018 Sep - Oct;38(5):476-490. doi: 10.1016/j.nefro.2017.12.006. Epub 2018 Apr 24. English, Spanish.

4.

Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.

Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S, Hadji P, Harvey NC, Kraenzlin M, Kurth A, McCloskey E, Minisola S, Thomas T, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Osteoporos Int. 2017 Nov;28(11):3285-3286. doi: 10.1007/s00198-017-4161-6. No abstract available.

PMID:
28785979
5.

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.

Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S, Hadji P, Harvey NC, Kraenzlin M, Kurth A, McCloskey E, Minisola S, Thomas T, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Osteoporos Int. 2017 Jul;28(7):2023-2034. doi: 10.1007/s00198-017-4009-0. Epub 2017 Apr 27. Erratum in: Osteoporos Int. 2017 Aug 7;:.

6.

Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Armbrecht G, Felsenberg D, Ganswindt M, Lunt M, Kaptoge SK, Abendroth K, Aroso Dias A, Bhalla AK, Cannata Andia J, Dequeker J, Eastell R, Hoszowski K, Lyritis G, Masaryk P, van Meurs J, Miazgowski T, Nuti R, Poór G, Redlund-Johnell I, Reid DM, Schatz H, Todd CJ, Woolf AD, Rivadeneira F, Javaid MK, Cooper C, Silman AJ, O'Neill TW, Reeve J; European Vertebral Osteoporosis Study and European Prospective Osteoporosis Study Groups.

Rheumatology (Oxford). 2017 Jul 1;56(7):1189-1199. doi: 10.1093/rheumatology/kex040.

7.

Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.

Evenepoel P, D'Haese P, Bacchetta J, Cannata-Andia J, Ferreira A, Haarhaus M, Mazzaferro S, Lafage Proust MH, Salam S, Spasovski G, Cozzolino M; ERA-EDTA Working Group on CKD-MBD.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1608-1613. doi: 10.1093/ndt/gfw468.

8.

Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.

Zoccali C, Mallamaci F, Cannata-Andía J.

Semin Dial. 2015 Nov-Dec;28(6):587-93. doi: 10.1111/sdi.12416. Epub 2015 Aug 17. Review.

PMID:
26278591
9.

The position of strontium ranelate in today's management of osteoporosis.

Reginster JY, Brandi ML, Cannata-Andía J, Cooper C, Cortet B, Feron JM, Genant H, Palacios S, Ringe JD, Rizzoli R.

Osteoporos Int. 2015 Jun;26(6):1667-71. doi: 10.1007/s00198-015-3109-y. Epub 2015 Apr 14. Review.

PMID:
25868510
10.

REFOS study: efficacy and safety of lanthanum carbonate in clinical practice in Spain.

Torregrosa JV, González-Parra E, González MT, Cannata-Andía J.

Nefrologia. 2014 May 21;34(3):360-8. doi: 10.3265/Nefrologia.pre2014.Mar.12287. English, Spanish.

11.

Spanish nephrologists and the management of mineral and bone metabolism disorders in chronic kidney disease.

Cannata-Andía J, Torregrosa JV.

Nefrologia. 2014;34(2):175-88. doi: 10.3265/Nefrologia.pre2014.Jan.12280. English, Spanish.

12.

Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.

Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernández E; Investigators from the NEFRONA Study.

Nephrol Dial Transplant. 2014 Jul;29(7):1415-22. doi: 10.1093/ndt/gfu038. Epub 2014 Feb 28.

PMID:
24586070
13.

Cancer-associated bone disease.

Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Glüer CC, Kendler D, Napoli N, Papaioannou A, Pierroz DD, Rahme M, Van Poznak CH, de Villiers TJ, El Hajj Fuleihan G; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease.

Osteoporos Int. 2013 Dec;24(12):2929-53. doi: 10.1007/s00198-013-2530-3. Epub 2013 Oct 22. Review.

14.

Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).

Torregrosa JV, Bover J, Cannata Andía J, Lorenzo V, de Francisco AL, Martínez I, Rodríguez Portillo M, Arenas L, González Parra E, Caravaca F, Martín-Malo A, Fernández Giráldez E, Torres A; Spanish Nephrology Society.

Nefrologia. 2011;31 Suppl 1:3-32. doi: 10.3265/Nefrologia.pre2011.Jan.10816. No abstract available. Erratum in: Nefrologia. 2011 Mar 22;31(2): following 240.

15.

Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction.

Torregrosa JV, Bover J, Cannata Andía J.

Nefrologia. 2011;31 Suppl 1:1-2. doi: 10.3265/Nefrologia.pre2011.Jan.10815. No abstract available.

16.

H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.

Martín-Garrido A, González-Ramos M, Griera M, Guijarro B, Cannata-Andia J, Rodriguez-Puyol D, Rodriguez-Puyol M, Saura M.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):567-73. doi: 10.1161/ATVBAHA.110.219725. Epub 2010 Dec 16.

PMID:
21164076
17.

Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H.

Palacín M, Alvarez V, Martín M, Díaz M, Corao AI, Alonso B, Díaz-Molina B, Lozano I, Avanzas P, Morís C, Reguero JR, Rodríguez I, López-Larrea C, Cannata-Andía J, Batalla A, Ruiz-Ortega M, Martínez-Camblor P, Coto E.

Mitochondrion. 2011 Jan;11(1):176-81. doi: 10.1016/j.mito.2010.09.004. Epub 2010 Sep 21.

PMID:
20863902
18.

A new role for vitamin D receptor activation in chronic kidney disease.

Valdivielso JM, Cannata-Andía J, Coll B, Fernández E.

Am J Physiol Renal Physiol. 2009 Dec;297(6):F1502-9. doi: 10.1152/ajprenal.00130.2009. Epub 2009 Jul 22. Review.

19.

Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council.

Covic A, Cannata-Andia J, Cancarini G, Coppo R, Frazão JM, Goldsmith D, Ronco P, Spasovski GB, Stenvinkel P, Utas C, Wiecek A, Zoccali C, London G.

Nephrol Dial Transplant. 2008 Dec;23(12):3731-7. doi: 10.1093/ndt/gfn519. Epub 2008 Sep 18. No abstract available.

PMID:
18802209
20.

[SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].

Torregrosa JV, Cannata Andia J, Bover J, Caravaca F, Lorenzo V, Martín de Francisco AL, Martín-Malo A, Martínez I, González Parra E, Fernández Giráldez E, Rodríguez Portillo M; Sociedad Española de Nefrologia.

Nefrologia. 2008;28 Suppl 1:1-22. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center